文献速递生殖医学

血抗苗勒管激素可能是复发性早期流产的一个决定因素,但尚不能预测再次流产

Blood anti-Müllerian hormone is a possible determinant of recurrent early miscarriage, yet not conclusive in predicting a further miscarriage.
PubMed 文献 · Reprod Biomed Online · 2019-04-12

研究比较188例不明原因复发性早期流产(REM)妇女与376例年龄匹配经产妇的血抗苗勒管激素(AMH)浓度,并对病例进行2年前瞻性随访。全人群AMH无显著差异;≥25岁亚组病例AMH显著低于对照,AMH<1 ng/ml比例显著更高。AMH与受孕延迟或再次流产均不相关,年龄和既往流产次数可显著预测再次流产。

要点

  • ≥25岁亚组病例AMH中位数2.8 ng/ml显著低于对照3.25 ng/ml(P=0.046)。
  • ≥25岁亚组病例AMH<1 ng/ml比例17.6%显著高于对照10.6%(OR 1.80,P=0.028)。
  • AMH浓度与受孕延迟及再次流产均不相关,不能预测后续妊娠结局。

核心结论

  • 卵巢储备改变可能是不明原因复发性早期流产的一个可能决定因素,但血AMH浓度既不预测受孕延迟也不预测后续妊娠结局。
  • 年龄增加和既往流产次数增多可显著预测再次流产(P=0.046和0.03)。

研究设计与样本

  • 第一部分为病例对照研究,病例为连续转诊的188例不明原因复发性早期流产(妊娠早期三次或以上流产)未选择(多为能生育)妇女,对照为376例年龄匹配、无妊娠丢失的经产妇。
  • AMH采用Immunotech ELISA试剂盒测定,血样采集于任何可识别的产科事件或激素治疗后>2个月。
  • 第二部分为对病例进行前瞻性2年随访。

主要发现

  • 全部妇女不分年龄时,病例与对照的AMH浓度无显著差异。
  • ≥25岁亚组(176例病例对358例对照,约33.5岁)中,病例AMH中位数(四分位距)2.8(1.4-4.7)ng/ml显著低于对照3.25(1.7-5.5)ng/ml(P=0.046)。
  • ≥25岁亚组中,病例AMH<1 ng/ml的比例17.6%显著高于对照10.6%(OR 1.80;95%CI 1.07-3.00,P=0.028)。
  • 关于后续妊娠,AMH浓度与受孕延迟或流产发生均不相关。
  • 年龄增加和既往流产次数增多可显著预测再次流产(P=0.046和0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is blood anti-Müllerian hormone (AMH) concentration a strong determinant of unexplained recurrent early miscarriage (REM)? DESIGN: In the first part of the study, AMH concentrations measured using an Immunotech ELISA Kit were compared between 188 unselected (mostly fertile) women consecutively referred for three or more miscarriages in the first trimester of pregnancy and 376 age-matched parous women without pregnancy loss. Cases and controls were previously enrolled in an incident case-control study on thrombophilic mutations. Blood samples were collected >2 months after any recognized obstetric event or hormonal treatment. In the second part of the study, a prospective 2-year follow-up of cases was performed. RESULTS: When considering all women irrespective of age, AMH concentration did not significantly differ between cases and controls. However, in the subgroup ≥25 years old (176 cases versus 358 controls of ∼33.5 years), the cases had significantly lower AMH concentrations than the controls (median [interquartile range]: 2.8 [1.4-4.7] versus 3.25 [1.7-5.5], P = 0.046) and the proportion of cases with an AMH concentration <1 ng/ml was significantly higher (17.6% versus 10.6%; odds ratio 1.80; 95% confidence interval 1.07-3.00, P = 0.028). With regard to the subsequent pregnancy, AMH concentration was not correlated with either the conception delay or the miscarriage occurrence. However, increased age and number of previous miscarriages were significantly predictive of a subsequent miscarriage (P = 0.046 and 0.03, respectively). CONCLUSION: An altered ovarian reserve is a possible determinant of unexplained REM. However, AMH blood concentration predicts neither the delay nor the outcome of a subsequent pregnancy.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Leclercq E, de Saint Martin L, Bohec C, et al. Blood anti-Müllerian hormone is a possible determinant of recurrent early miscarriage, yet not conclusive in predicting a further miscarriage. Reprod Biomed Online. 2019. PMID: 31186176. doi:10.1016/j.rbmo.2019.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。